Related Experiment Video
Updated: May 31, 2026

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential
Developing targeted nano-theranostic vehicles can overcome challenges in delivering therapeutics for chronic obstructive lung diseases like cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). This strategy aims for sustained drug delivery, improved efficacy, and penetration of airway defenses.
Area of Science:
- Nanomedicine
- Pulmonary Medicine
- Theranostics
Background:
- Chronic obstructive lung diseases, including asthma, COPD, and CF, are characterized by airway inflammation and mucous hypersecretion.
- Current treatments struggle with sustained drug delivery to target cells and tissues due to airway defenses.
- Infection and cigarette smoke exacerbate inflammation and mucous production in these conditions.
Discussion:
- Targeted nanoparticle-mediated delivery is crucial for managing COPD by controlling inflammation, fibrosis, and lung obstruction.
- Epithelial delivery is essential for correcting defects in CF, while inflammatory cell targeting is key for other chronic lung diseases.
- Nano-based theranostic vehicles offer potential for simultaneous therapy and imaging, aiding treatment of chronic obstructive lung diseases.
Key Insights:
- Nano-theranostic vehicles can be designed with therapeutic, imaging, and airway-defense penetrating capabilities.
- Targeted delivery systems are necessary to address the specific needs of different chronic obstructive lung diseases.
- Overcoming challenges in drug delivery is paramount for improving therapeutic efficacy in pulmonary conditions.
Outlook:
- Further evaluation of novel nano-theranostic strategies is needed to treat the underlying causes of CF and COPD.
- Development of advanced nanocarriers could revolutionize the treatment of chronic inflammatory lung diseases.
- Personalized nanomedicine approaches may enhance treatment outcomes for patients with obstructive airway conditions.
More Related Videos
05:45A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
Published on: January 16, 2026
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment